COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 10, 2017 |
Dec. 10, 2015 |
Sep. 01, 2015 |
Jul. 28, 2016 |
Mar. 21, 2016 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Mar. 08, 2017 |
Mar. 09, 2016 |
Mar. 07, 2016 |
Nov. 20, 2015 |
Oct. 19, 2015 |
|
Rent expense | $ 41,533 | $ 40,736 | ||||||||||
Failure to pay for legal services | $ 59,174 | |||||||||||
Compensation | 0 | 0 | ||||||||||
Settlement agreement to pay the plaintiff | $ 65,000 | |||||||||||
Accruals | 65,000 | |||||||||||
Description of settlement agreement |
The remaining balance of $60,000 shall be paid in twelve (12) monthly payments of $5,000 each through April 1, 2018. |
|||||||||||
Settlements payable, short term | $ 250,000 | $ 190,000 | ||||||||||
Accounts payable | 195,845 | 15,000 | 250,000 | |||||||||
Notes payable | $ 54,155 | 172,748 | ||||||||||
Alpine Creek Capital Partners LLC [Member] | ||||||||||||
Total royalty payable | $ 405,000 | |||||||||||
Deposit amount | $ 55,000 | |||||||||||
Cancellation of secured promissory note | $ 55,000 | |||||||||||
Payables to the Company | 295,000 | |||||||||||
Payables to Alpine Creek | $ 1,215,000 | |||||||||||
Payable commitment description |
In the event that the Company has not paid Alpine Creek $1,215,000 within 24 months of the Effective Date, then the Company shall continue to pay Alpine Creek fifty percent (50%) for each Treatment following the Effective Date until the Company has paid Alpine Creek an aggregate of $1,620,000, with the exception of treatments conducted in certain territories |
|||||||||||
Payable per treatment sold | $ 100 | |||||||||||
Profit holding percentage | 50.00% | |||||||||||
Employment and consulting agreements [Member] | ||||||||||||
Compensation | $ 75,000 | |||||||||||
Chief Executive Officer [Member] | ||||||||||||
Unpaid compensation, bonuses and previous loans in aggregate | $ 316,000 | |||||||||||
Therakine, Ltd. [Member] | ||||||||||||
License cost | $ 2,750,000 | |||||||||||
Aggregate purchase price | $ 250,000 | $ 250,000 | 250,000 | |||||||||
Escrow deposit | $ 75,000 | |||||||||||
Therakine, Ltd. [Member] | Minimum [Member] | ||||||||||||
Sales of products | 5.00% | |||||||||||
Therakine, Ltd. [Member] | Maximum [Member] | ||||||||||||
Sales of products | 12.00% |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No definition available.
|
X | ||||||||||
- Definition Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of judgment or settlement awarded to (against) the entity in respect of litigation. No definition available.
|
X | ||||||||||
- Definition Description of the terms of a settlement agreement which resolved the legal matter, including the nature of the consideration, timing of payment, and the nature of rights obtained or lost (for example, but not limited to, patent, trademark, copyright, license and franchise rights). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The net cash inflow or outflow associated with the aggregate amount of adjustment to the purchase price of a previous acquisition. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|